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REVIEWS
Ca2+ is a highly versatile intracellular signal that can reg-
ulate many different cellular functions1,2. To achieve this
versatility, the Ca2+-signalling system operates in many
different ways to regulate cellular processes that func-
tion over a wide dynamic range (FIG. 1). At the synaptic
junction, for example, Ca2+ triggers exocytosis within
microseconds, whereas at the other end of the scale Ca2+
has to operate over minutes to hours to drive events
such as gene transcription and cell proliferation. One of
the challenges is to understand how these widely differ-
ent Ca2+-signalling systems can be set up to control so
many divergent cellular processes.
At any moment in time, the level of intracellular
Ca2+ is determined by a balance between the ‘on’ reac-
tions that introduce Ca2+ into the cytoplasm and the
‘off ’ reactions through which this signal is removed by
the combined action of buffers, pumps and exchangers
(FIG. 1). During the on reaction, a small proportion of
the Ca2+ binds to the effectors that are responsible for
stimulating numerous Ca2+-dependent processes (FIG. 1).
These heterogeneous Ca2+-signalling systems are assem-
bled from an extensive Ca2+-signalling toolkit1 (BOX 1).
Through alternative splicing, many of the toolkit com-
ponents have different isoforms with subtly different
properties, which further expands the versatility of Ca2+
signalling.
This review concentrates on the nature of the Ca2+-
signalling toolkit and how it is exploited to create many
different Ca2+-signalling systems. We have gathered
emerging evidence that the expression patterns of the
different signalling components might be regulated
by Ca2+ itself to set up a ‘self-assessment system’ to
ensure that these signalling systems remain constant.
Alterations in this Ca2+-dependent homeostatic mecha-
nism might be the cause of many prominent diseases, as
exemplified by end-stage heart failure.
Ca2+-signalling toolkit and signalling dynamics
Each cell type expresses a unique set of components
from the Ca2+-signalling toolkit to create Ca2+-signalling
systems with different spatial and temporal properties.
Almost all Ca2+-signalling systems have one thing in
common — they function by generating brief pulses
of Ca2+. These Ca2+ transients are created by variations
of the basic on/off reactions that are outlined in FIG. 1.
Signal Ca2+ is derived either from internal stores or
from the external medium (FIG. 1). In the case of the lat-
ter, there are many different plasma-membrane chan-
nels (BOX 1) that control Ca2+ entry from the external
medium in response to stimuli that include membrane
depolarization, stretch, noxious stimuli, extracellular
agonists, intracellular messengers and the depletion of
intracellular stores. The release of Ca2+ from the internal
store — usually the endoplasmic reticulum (ER) or its
muscle equivalent, the sarcoplasmic reticulum (SR) —
is controlled by Ca2+ itself, or by an expanding group of
messengers3, such as inositol-1,4,5-trisphosphate
(Ins(1,4,5)P
3
), cyclic ADP ribose (cADPR), nicotinic
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oscillations that are required to activate mammalian
eggs during fertilization is generated by a newly discov-
ered PLC, PLCζ, that is injected into the egg by the
sperm5 (FIG. 2).
The dynamics of Ins(1,4,5)P
3
production can be
very different depending on the receptor type being
activated6. Bradykinin and neurokinin A receptors give
large rapid Ca2+ transients, whereas lysophosphatidic
acid (LPA), thrombin and histamine receptors give
smaller responses that develop slowly but persist for
much longer. Some of this variability might arise from
the fact that receptors engage different transducing ele-
ments and PLC isoforms in a cell-type-specific man-
ner7,8. For example, at the parallel fibre/Purkinje cell
synapse, glutamate operates through a metabotropic
glutamate receptor type I (mGluR1)→G
qα
→PLCβ4→
Ins(1,4,5)P
3
→ Ins(1,4,5)P
3 
receptor 1 (Ins(1,4,5)P
3
R1)
→Ca2+ cascade, whereas hippocampal neurons respond
to the same agonist using a mGluR5→G
11α
→PLCβ1→
Ins(1,4,5)P
3
→Ins(1,4,5)P
3
R→Ca2+ sequence. The reason
why neurons use these different signalling cascades is not
known, but there is evidence from other cell types that
mGluR1 and mGluR5 can result in radically different
Ca2+ signals9. mGluR1 produces a single Ca2+ transient,
whereas mGluR5 generates an oscillatory pattern.
Another example is found in pancreatic acinar cells in
which muscarinic receptors generate small, highly local-
ized Ca2+ transients, whereas the cholecystokinin (CCK)
receptors produce much larger global Ca2+ transients.
These different outputs might depend on the action of
the regulators of G-protein signalling (RGS)10. In com-
parison to CCK receptors, muscarinic receptors are
much more sensitive to the inhibitory action of RGS pro-
teins (RGS2, RGS4 and RGS16), and this might limit the
supply of Ins(1,4,5)P
3
. Qualitatively different Ca2+ signals
might also arise if receptors combine Ins(1,4,5)P
3
with
other  Ca2+-mobilizing messengers/modulators such as
cADPR or NAADP11–13, as discussed in the next section.
cADPR and NAADP. These two nucleotides mobilize
intracellular Ca2+ through different mechanisms, even
though they are generated through the same enzymatic
pathway14 (FIG. 2). Mammalian cells express CD38, which
is a multifunctional ADP ribosyl cyclase with both syn-
thase and hydrolase activity. The synthase component of
CD38 can use either NAD to produce cADPR or NADP
to generate NAADP. CD38 has been located both on the
cell surface and on intracellular membranes. On the cell
surface, CD38 has been suggested to both produce
cADPR and NAADP and to transport them into cells.
Different activation mechanisms have been proposed
for the cytosolic enzyme. External agonists might acti-
vate it, but a consistent mechanism for the transduction
process is still lacking. An alternative possibility is that
the formation of cADPR and NAADP is sensitive to cel-
lular metabolism (FIG. 2). In other words, cADPR and
NAADP might be metabolic messengers that can relay
information about the state of cellular metabolism to
the Ca2+-signalling pathways. Such an idea is supported
by the fact that cADPR metabolism by the hydrolase is
inhibited by either ATP15 or NADH16 (FIG. 2).
acid adenine dinucleotide phosphate (NAADP) and
sphingosine-1-phosphate (S1P), that either stimulate or
modulate the release channels on the internal stores.
Inositol-1,4,5-trisphosphate. Many stimuli function
through PHOSPHOLIPASE C (PLC) to generate Ins(1,4,5)P
3
that functions to release Ca2+ from an internal store1
(FIG. 2). There are several PLC isoforms (BOX 1) that are
activated by different mechanisms, such as G-protein-
coupled receptors (PLCβ), tyrosine-kinase-coupled
receptors (PLCγ), an increase in Ca2+ concentration
(PLCδ) or activation through Ras (PLCε)4. The
Ins(1,4,5)P
3
that is responsible for triggering the Ca2+
Figure 1 | Calcium-signalling dynamics and homeostasis.
During the ‘on’ reactions, stimuli induce both the entry of
external Ca2+ and the formation of second messengers that
release internal Ca2+ that is stored within the endoplasmic/
sarcoplasmic reticulum (ER/SR). Most of this Ca2+ (shown as
red circles) is bound to buffers, whereas a small proportion
binds to the effectors that activate various cellular processes
that operate over a wide temporal spectrum. During the ‘off’
reactions, Ca2+ leaves the effectors and buffers and is removed
from the cell by various exchangers and pumps. The Na+/Ca2+
exchanger (NCX) and the plasma-membrane Ca2+-ATPase
(PMCA) extrude Ca2+ to the outside, whereas the
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pumps
Ca2+ back into the ER. Mitochondria also have an active
function during the recovery process in that they sequester Ca2+
rapidly through a uniporter, and this is then released more slowly
back into the cytosol to be dealt with by the SERCA and the
PMCA. Cell survival is dependent on Ca2+ homeostasis,
whereby the Ca2+ fluxes during the off reactions exactly match
those during the on reactions. [Ca2+], Ca2+ concentration;
Ins(1,4,5)P3R, inositol-1,4,5-trisphosphate receptor; 
RYR, ryanodine receptor.
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Box 1 | Calcium-signalling toolkit
The Ca2+-signalling system has a very large toolkit of signalling components that can be mixed and matched to create a
diverse array of signalling units that can deliver Ca2+ signals with very different spatial and temporal properties. The
following list is by no means inclusive but it summarizes some of the main toolkit components in mammalian cells:
Receptors
G-protein-coupled receptors: muscarinic receptors (M1–3) | adrenoceptors (α
1A–C
) | angiotensin receptor (AT
1
) |
bombesin receptors (BRS-1, BRS-2) | bradykinin receptors (B
1
, B
2
) | cholecystokinin receptors (CCK
1
, CCK
2
) | endothelin
receptors (ET
A
, ET
B
) | metabotropic glutamate receptors (mGlu1, mGlu5) | luteinizing receptor (LSH) | histamine receptor
(H
1
) | 5-Hydroxytryptamine receptors (5-HT
2A
, 5-HT
2B
, 5-HT
2C
) | leukotrine receptors (BLT, CysLT
1
, CysLT
2
) | neurotensin
receptor (NTS1) | oxytocin receptor (OT) | extracellular Ca2+-sensing receptor (CaR) | prostanoid receptor (PGF
2α
) |
thrombin receptor (PAR1) | substance P receptor (NK
1
) | substance K receptor (NK
2
) | substance B receptor (NK
3
) |
thyrotropin-releasing hormone receptor (TRHR) | vasopressin receptors (V
1A
,V
1B
) 
Tyrosine-kinase-linked receptors: platelet-derived growth factor receptors (PDGFRα, PDGFRβ) | epidermal growth
factor receptors (ERBB1–4)
Transducers
G proteins: G
qα
, G
11α
, G
14α
, G
16α
| Gβγ
Regulators of G-protein signalling (RGS): RGS1 | RGS2 | RGS4 | RGS16
Phospholipase C (PLC): PLCβ1–4 | PLCγ1, PLCγ2 | PLCδ1–4 | PLCε | PLCζ
ADP ribosyl cyclase: CD38
Channels
Voltage-operated channels (VOCs): Ca
V
1.1, Ca
V
1.2, Ca
V
1.3, Ca
V
1.4 (L-type) | Ca
V
2.1 (P/Q-type) | Ca
V
2.2 (N-type) | 
Ca
V
2.3 (R-type) | Ca
V
3.1, Ca
V
3.2, Ca
V
3.3 (T-type)
Receptor-operated channels (ROCs): NMDA receptors (NR1, NR2A, NR2B, NR2C, NR2D) | ATP receptor (P2X
7
) | 
nACh receptor
Second-messenger-operated channels (SMOCs): cyclic nucleotide gated channels (CNGA 1–4, CNGB 1, CNGB 3) |
arachidonate-regulated Ca2+ channel (I
ARC
)
Transient receptor potential (TRP) ion-channel family: TRPC1–7 | TRPV1–6 | TRPM1–8 | TRPML (mucolipidin 1,2) |
TRPNI (ANKTM1)
Inositol-1,4,5-trisphophate receptors (Ins(1,4,5)P
3
Rs): Ins(1,4,5)P
3
R1–3
Ryanodine receptors (RYRs): RYR1–3
Polycystins: PC-1 | PC-2 
Channel regulators: triadin | junctin | sorcin | FKBP12 | FKBP12.6 | phospholamban | IRAG | IRBIT
Calcium buffers
Cytosolic buffers: calbindin D-28 | calretinin | parvalbumin
ER/SR buffers and chaperones: calnexin | calreticulin | calsequestrin | GRP 78 | GRP 94
Calcium effectors
Ca2+-binding proteins: calmodulin | troponin C | synaptotagmin | S100A1–12, S100B, S100C, S100P | annexin I–X |
neuronal Ca2+ sensor family (NCS-1) | visinin-like proteins (VILIP-1,VILIP-2,VILIP-3) | hippocalcin | recoverin | 
Kv-channel-interacting proteins (KchIP1–3) | guanylate-cyclase-activating proteins (GCAP1–3)
Calcium-sensitive enzymes and processes
Ca2+-regulated enzymes: Ca2+/calmodulin-dependent protein kinases (CaMKI–IV) | myosin light chain kinase (MLCK) |
phosphorylase kinase | Ins(1,4,5)P
3
3-kinase | PYK2 | protein kinase C (PKC-α, PKC-βI, PKC-βII, PKC-γ) | cyclic AMP
phosphodiesterase (PDE1A–C) | adenylyl cyclase (AC-1, AC-III, AC-VIII, AC-V, AC-VI) | nitric oxide synthase
(endothelial NOS, eNOS; neuronal NOS, nNOS) | calcineurin | Ca2+-activated proteases (calpain I and II)
Transcription factors: nuclear factor of activated T cells (NFATc1–4) | cyclic AMP response element-binding protein
(CREB) | downstream regulatory element modulator (DREAM) | CREB-binding protein (CBP)
Ca2+-sensitive ion channels: Ca2+-activated potassium channels (SK, small conductance Ca2+-sensitive channel;
IK, intermediate conductance Ca2+-sensitive channel; BK, large conductance Ca2+-sensitive channel) | Human Cl– channel,
Ca2+-activated (HCLCA1)
Calcium pumps and exchangers
Na+/Ca2+ exchangers (NCXs): NCX1–3
Mitochondrial channels and exchangers: permeability transition pore | Na+/Ca2+ exchanger | Ca2+ uniporter | 
H+/Ca2+ exchanger
Plasma membrane Ca2+-ATPases (PMCAs): PMCA1–4
Sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs): SERCA1–3
Golgi pumps: SPCA1, SPCA2
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long latency20,21, which indicates that it might be function-
ing indirectly by increasing the Ca2+ sensitivity of RYRs, as
has been shown in neurons18,19,22 and in the heart21,23. In
these two excitable cells, VOLTAGE-OPERATED CHANNELS (VOCs)
respond to membrane depolarization by admitting a
small pulse of Ca2+, which then stimulates the RYRs
to release further Ca2+ through CICR (FIG. 2). The degree
to which the initial entry signal is amplified by CICR,
which is referred to as the ‘gain’ of the signalling system,
can be regulated by cADPR. This might have pathological
consequences, as cardiac arrhythmias can develop if
cADPR sets the gain too high24.
Just how cADPR functions to modulate the sensitiv-
ity of the RYRs is still unclear. One view is that cADPR
functions as a messenger to stimulate Ca2+ release by the
RYRs14. However, cADPR does not seem to bind directly
to the RYR, instead it seems to function through some
intermediary — the FK506-binding protein 12.6
(FKBP12.6), which is a subunit that is associated with
the RYR (BOX 2, part a), has been suggested as a possible
candidate25. An alternative view is that cADPR functions
by activating the SARCO(ENDO)PLASMIC RETICULUM Ca2+-ATPASE
(SERCA) pump23. Such an indirect action is consistent
with many of the properties of cADPR. By stimulating
the SERCA pump, cADPR would enhance the load of
Ca2+ within the lumen of the ER — a process that is
known to increase the Ca2+ sensitivity of RYRs23,26 (FIG. 2).
Sphingolipid-derived messengers. Some agonist-
evoked Ca2+ signals might be controlled by a sphin-
golipid-activated Ca2+-release pathway that functions
independently of Ins(1,4,5)P
3
Rs or RYRs27. In mast
cells, the sphingolipid-derived messenger S1P func-
tions together with Ins(1,4,5)P
3
to generate the Ca2+
signals that underlie the synthesis and release of
inflammatory mediators. The dual activation of these
pathways leads to a Ca2+ signal with a rapid peak (S1P
dependent) and a sustained plateau (Ins(1,4,5)P
3
dependent)28. Exactly how S1P stimulates Ca2+ release
from intracellular stores is unclear. Until recently, the
best candidate for the S1P receptor was a widely
expressed protein known as SCaMPER (sphingolipid
Ca2+-release-mediating protein of endoplasmic reticu-
lum). However, it has no similarity to any known
intracellular Ca2+ channel and is a small (~20-kDa)
protein with only one transmembrane domain. A
recent reinvestigation of SCaMPER showed that
there was little correlation between its intracellular
location and that of known intracellular Ca2+ stores.
Furthermore, expression of SCaMPER was found not
to confer sensitivity to sphingolipids or to affect Ca2+
homeostasis, but could lead to cell death29.
Ca2+-entry mechanisms. Ca2+ that enters the cell from
the outside is a principal source of signal Ca2+ during
the on reaction (FIG. 1). Entry of Ca2+ is driven by the
presence of a large electrochemical gradient across
the plasma membrane. Cells use this external source
of signal Ca2+ by activating various entry channels
with widely different properties. We know the most
about the VOCs, which are found in excitable cells
NAADP functions by releasing Ca2+ from an internal
store, which was recently identified in sea urchin eggs
as a reserve granule store. This store is distinct from the
stores that are regulated by Ins(1,4,5)P
3
Rs and RYANODINE
RECEPTORS (RYRs), because the latter stores can be
depleted without affecting the ability of NAADP to
release Ca2+. This separate reserve granule store might be
equivalent to a lysosome-related organelle in mam-
malian cells17 (FIG. 2). In contrast to the Ins(1,4,5)P
3
Rs
and RYRs, the NAADP release mechanism is not sensi-
tive to Ca2+ and therefore does not support the process
of Ca2+-INDUCED Ca2+ RELEASE (CICR). NAADP seems to have
a role in both initiating and coordinating various Ca2+-
signalling systems11,12. NAADP might sensitize the
Ins(1,4,5)P
3
Rs and RYRs through two mechanisms (FIG.2):
it might function directly by providing trigger Ca2+, or
indirectly by releasing a bolus of Ca2+, which is then
taken up by the other stores in which it can sensitize the
release channels by functioning from the lumen.
The function of cADPR resembles that of a modula-
tor rather than a messenger.When cADPR is introduced
into cells there usually is no immediate effect18,19. In those
cases in which it elicits a Ca2+ response, there usually is a
RYANODINE RECEPTOR
(RYR). A Ca2+-release channel
that is located in the membrane
of the endoplasmic/sarcoplasmic
reticulum and is regulated by
several factors including Ca2+
itself, as well as the intracellular
messenger cyclic ADP ribose.
Ca2+-INDUCED Ca2+ RELEASE
(CICR). An autocatalytic
mechanism by which
cytoplasmic Ca2+ activates the
release of Ca2+ from internal
stores through channels such as
inositol-1,4,5-trisphosphate
receptors or ryanodine
receptors.
VOLTAGE-OPERATED CHANNEL
(VOC). A plasma-membrane
ion channel that is activated by
membrane depolarization.
Figure 2 | Calcium-mobilizing messengers and modulators. Various second messengers or
modulators regulate the release of Ca2+ from internal stores by the inositol-1,4,5-trisphosphate
receptor (Ins(1,4,5)P3R) or the ryanodine receptor (RYR). These release channels are sensitive to
factors that function from the cytosol and from within the lumen of the endoplasmic/sarcoplasmic
reticulum (ER/SR). The Ins(1,4,5)P3R is regulated by inositol-1,4,5-trisphosphate (Ins(1,4,5)P3),
which is generated by various signalling pathways using different isoforms of phospholipase C
(PLC; β, δ, ε, γ and ζ). The nucleotides cyclic ADP ribose (cADPR) and nicotinic acid adenine
dinucleotide phosphate (NAADP) are generated by ADP ribosyl cyclase, which has both synthase
(S) and hydrolase (H) activity. This dual-function enzyme might be sensitive to the cellular
metabolism, as ATP and NADH inhibit the hydrolase. Just how cADPR and NAADP function is still
unclear, but they seem to have an indirect action. cADPR might function by stimulating the
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pump, which increases the luminal level of
Ca2+, which results in sensitization of the RYR. NAADP functions through a channel that is located
on a lysosomal-like organelle to release Ca2+ that can either stimulate the Ins(1,4,5)P3R or the
RYR directly, or might function indirectly, like cADPR, to increase the lumenal level of Ca2+.
PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate.
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are sensitive to a diverse array of stimuli, such as the
STORE-OPERATED CHANNELS (SOCs), thermosensors and
stretch-activated channels. Many of these channels
belong to the large transient receptor protein (TRP)
ion-channel family31–34, which are encoded by up to 23
different genes. This family consists of three groups —
the canonical TRPC family, the vanilloid TRPV family
and the melastatin TRPM family (BOX 1). TRP channels
tend to have low conductances and therefore can oper-
ate over much longer time scales without swamping the
cell with too much Ca2+. Members of the TRP family are
particularly important in controlling slow cellular
processes such as smooth-muscle contractility and cell
proliferation.
and generate the rapid Ca2+ fluxes that control fast
cellular processes such as muscle contraction or exo-
cytosis at synaptic endings (BOX 2, part c).
There are many other Ca2+-entry channels (BOX 1)
that open in response to different external signals, such
as the RECEPTOR-OPERATED CHANNELS (ROCs), for example
the NMDA (N-methyl-D-aspartate) receptors (NMDARs)
that respond to glutamate (BOX 2, part b). There also are
SECOND-MESSENGER-OPERATED CHANNELS (SMOCs) that are
controlled by internal messengers, such as the cyclic-
nucleotide-gated channels that are found in sensory sys-
tems and the arachidonic-acid-sensitive channel30. In
addition to these more clearly defined channel-opening
mechanisms, there are many other channel types that
SARCO(ENDO)PLASMIC
RETICULUM Ca2+-ATPASE
(SERCA). A pump located in
sarcoplasmic or endoplasmic
reticulum membranes that
couples ATP hydrolysis to the
transport of Ca2+ from cytosolic
to lumenal spaces.
RECEPTOR-OPERATED CHANNEL
(ROC). A plasma-membrane
ion channel that opens in
response to the binding of an
extracellular ligand.
Box 2 | Multimolecular complexes of calcium-signalling components
Like many other signalling systems, the components of the
different Ca2+-signalling systems are often grouped together into
large complexes.
The RYR2 Ca2+-release complex in cardiac cells
Ryanodine receptor 2 (RYR2) is composed of four subunits that
form the channel, which is associated with various proteins that
function to modulate its opening (see figure, part a). The
endoplasmic/sarcoplasmic reticulum (ER/SR) luminal Ca2+-
binding protein calsequestrin (CSQ) modulates the sensitivity of
RYR2 (FIG. 2). The interaction between CSQ and RYR2 is facilitated
by the transmembrane proteins triadin and junctin. The reversible
phosphorylation of RYR2 by cyclic AMP (cAMP) is controlled by
protein kinase A (PKA), which is composed of regulatory (R) and
catalytic (C) subunits that are attached through an A kinase
anchoring protein (AKAP). Dephosphorylation depends on
protein phosphatase 2A (PP2A), which is attached through the
isoleucine-zipper-binding scaffolding protein PR130, and on
protein phosphatase 1 (PP1), which is attached through
spinophilin (SP). RYR2 is also modulated by calmodulin (CaM)
and by FK506-binding protein 12.6 (FKBP12.6).
NMDA and Ins(1,4,5)P
3
receptor complexes in neurons
Glutamate-induced Ca2+ entry is carried out by NMDA (N-methyl-
D-aspartate) receptors (NMDARs) that are linked to other
signalling components (see figure, part b), some of which are Ca2+
sensitive, such as Ca2+/CaM-dependent kinase II (CaMKII) and
neuronal nitric oxide synthase (nNOS). NMDARs are also
associated with other proteins such as yotiao (Y), which binds PP1,
and the scaffolding protein PSD95, which links into other
signalling components such as the AKAP–PKA complex and
guanylate kinase-associated protein (GKAP). Proteins such as
shank and Homer (H) might link the metabotropic glutamate
receptor (mGluR) to both the NMDAR and the inositol-1,4,5-
trisphospate receptor (Ins(1,4,5)P
3
R), which is also associated with
a Ca2+-binding protein (CaBP).
Synaptic-vesicle complex
The exocytotic release of synaptic vesicles, which occurs within
microseconds of membrane depolarization, is activated by an influx
of Ca2+ through the Ca
V
2 voltage-operated channels (see figure, part c),
for example, the P/Q-, N- and R-type VOCs (BOX 1). These entry
channels have a binding site that anchors them to components of
the exocytotic machinery such as syntaxin or SNAP-25. In this way,
the Ca2+ that enters through the channel has immediate access to the
synaptotagmin Ca2+ sensor that is thought to initiate the fusion
event that is carried out by syntaxin, SNAP-25 and synaptobrevin.
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and calnexin, which are Ca2+-binding proteins that are
known to interact with the Ins(1,4,5)P
3
R. The Ca2+-
binding sites on calreticulin have affinities that are suffi-
ciently low to enable them to regulate Ins(1,4,5)P
3
Rs
through luminal Ca2+ levels.
The InsP
3
R can also be modulated by other signalling
pathways, including phosphorylation by Ca2+/CaM-
dependent  kinase II (CaMKII), cGMP-dependent protein
kinase (PKG), protein kinase C (PKC) and cAMP-
dependent protein kinase (protein kinase A; PKA)2. For
some of these kinases, the scaffolding proteins that medi-
ate recruitment to their site of action on the Ins(1,4,5)P
3 
R
have been identified. For example, PKG is recruited by the
Ins(1,4,5)P
3
R-associated cGMP kinase substrate (IRAG),
which results in Ins(1,4,5)P
3
R phosphorylation and a
decrease in receptor activity39. In B cells, the Ins(1,4,5)P
3
R
is phosphorylated by the tyrosine kinase Lyn,which results
in increased activity. This phosphorylation event is facili-
tated by the scaffolding protein Bank that links together
Lyn, the Ins(1,4,5)P
3
R and the B-cell receptor40. Similarly,
in neuronal cells Ins(1,4,5)P
3
Rs are tethered to mGluRs by
the Homer protein, thereby linking the source of
Ins(1,4,5)P
3 
production to its site of action (BOX 2, part b).
The protein phosphatases 1 and 2a (PP1 and PP2a) have
been found to co-purify with PKA and the Ins(1,4,5)P
3
R,
which is reminiscent of their interaction with the RYR41.
This protein complex of phosphatase,kinase and substrate
allows the rapid regulation of Ins(1,4,5)P
3
R activity by
phosphorylation/dephosphorylation.
RYRs are also controlled by several signalling path-
ways, as illustrated by the RYR2 that is found in cardiac
cells. Like the Ins(1,4,5)P
3
R, RYR2 responds to Ca2+ in
a bell-shaped fashion (that is, RYR2 is inactive at low
nM concentrations of Ca2+, active at low µM concen-
trations of Ca2+ and inactivated by high concentrations
of Ca2+ that are in the mM range)42. In the cardiac
myocyte,Ca2+ that enters through the L-type Ca2+ channel
activates RYR2 to create the ‘spark’ that triggers con-
traction (FIG. 3). This role of RYR2 in excitation–contrac-
tion (E–C) coupling is a highly regulated process that
involves many accessory factors that are bound to both
its luminal and cytosolic domains (BOX 2, part a).
Opening of RYR2 is inhibited by CaM, which is pre-
sent in Ca2+-bound and non-bound forms, which are
known as CaCaM and apoCaM, respectively43. Several
accessory proteins contribute to the control of heart
function by the sympathetic nervous system, through
the FIGHT-OR-FLIGHT RESPONSE44. After β-adrenergic stimula-
tion, RYR2 is phosphorylated by PKA, which is attached
through an A kinase anchoring protein (AKAP)45 (BOX 2,
part a). Phosphorylation of RYR2 by PKA results in the
dissociation of the 12.6-kDa FKBP12.6, which normally
stabilizes the RYR in a closed conformation45.
Furthermore, FKBP12.6 is required for the coupled gat-
ing between neighbouring receptors that coordinates
the activation and inactivation of physically linked
receptors during E–C coupling44. PKA also phosphory-
lates sorcin, which is another regulator of RYR2 (REF. 46).
The RYR2 macromolecular complex also includes
the phosphatases PP1 and PP2a, which interact with
RYR2 through the leucine/isoleucine-zipper-binding
Ca2+ release from internal stores. The other principal
source of Ca2+ for signalling is the internal stores that are
located primarily in the ER/SR, in which Ins(1,4,5)P
3
Rs
or RYRs regulate the release of Ca2+ (FIG. 2). These two
channels are sensitive to Ca2+, and this CICR process
contributes to the rapid rise of Ca2+ levels during the on
reaction and the development of regenerative Ca2+
waves. In addition to Ca2+, these channels are regulated
by many different factors that operate on both the lumi-
nal and cytosolic surfaces of the channel (BOX 2, part a).
In the case of the Ins(1,4,5)P
3
Rs, the primary deter-
minants are Ins(1,4,5)P
3 
and Ca2+. The binding of
Ins(1,4,5)P
3
increases the sensitivity of the receptor to
Ca2+, which has a biphasic action (that is, it activates at
low concentrations, but becomes inhibitory at the
higher concentrations that occur after Ca2+ release). This
Ca2+ regulation is mediated by the direct action of Ca2+
on the receptor, as well as indirectly through calmodulin
(CaM), which can be activating or inhibitory35,36.
Recently, a Ca2+-binding protein (CaBP) was shown to
activate Ca2+ release in the absence of Ins(1,4,5)P
3
(REF 37). However, this new function for CaBP is con-
tentious38. In addition to these cytosolic actions, Ca2+
can also sensitize the Ins(1,4,5)P
3 
R by functioning from
the lumen (FIG. 2). This luminal sensitivity might be con-
ferred by the ER luminal lectin chaperones calreticulin
Figure 3 | Cardiac calcium-signalling module. This self-contained module generates the
localized Ca2+ ‘sparks’ that are responsible for activating contraction and perhaps also gene
transcription (Ca2+ is shown as red circles). Signalling begins with an amplification step in the
junctional zone, where the L-type channel on the T-tubule membrane responds to depolarization
by introducing a small pulse of trigger Ca2+, which then diffuses across the narrow gap of the
junctional zone to activate ryanodine receptor 2 (RYR2) (BOX 2, part a) to generate a spark. Ca2+
from this spark diffuses out to activate contraction. Recovery occurs as Ca2+ is pumped out of the
cell by the Na+/Ca2+ exchanger (NCX) or is returned to the sarcoplasmic reticulum (SR) by
sarco(endo)plasmic Ca2+-ATPase (SERCA) pumps on the non-junctional region of the SR. A
proportion of this Ca2+ travels through the mitochondria, during which time it stimulates the
metabolism to provide the ATP that is necessary to maintain contraction and transcription. The
Ca2+ that is returned to the SR ‘tunnels’ back to the junctional zone to be used again for
subsequent heart beats. This circulation of Ca2+ is modulated by second messengers such as
cyclic AMP (cAMP), which removes the inhibitory action of phospholamban (PLN), or by cyclic
ADP ribose (cADPR) that activates the pump to increase the amount of releasable Ca2+ in the SR.
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ion channel that opens in
response to the binding of
intracellular second messengers
such as diacylglycerol, cyclic
nucleotides or arachidonic acid.
STORE-OPERATED CHANNEL
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compare the buffering capacity of cells. Some cells, such
as motoneurons and adrenal chromaffin cells, have K
S
values of approximately 40, but this can increase to values
as high as 2,000 in Purkinje neurons54. The low buffering
capacity of motoneurons enables them to generate rapid
Ca2+ signals, but this does make them much more sus-
ceptible to excitotoxic stress, which might contribute to
motoneuron disease54.
The importance of buffers in Ca2+ signalling has
emerged from studying transgenic animals in which indi-
vidual buffers have been deleted.When the PV gene that
encodes PV is knocked out, the relaxation of fast-twitch
muscles is impaired, but they become fatigue resistant
through a remarkable compensatory mechanism that
involves an upregulation of the mitochondria, which
increases their capacity to sequester Ca2+, such that they
can partially replace the loss of PV55. These PV–/– animals
also have defects in their short-term synaptic plasticity56
owing to defects in Ca2+ signalling.
Several different effectors, such as troponin C, CaM,
synaptotagmin, S100 proteins and the annexins (BOX 1),
are responsible for activating different Ca2+-sensitive
cellular processes. For those processes that respond
rapidly, there is a close juxtaposition of the signalling
and effector components as occurs for the pre-synaptic
and post-synaptic events in neurons (BOX 2, parts b,c).
For those processes that operate over longer time scales,
such as cell proliferation, Ca2+ functions more globally
(see below).
Pumps and exchangers. During the course of a typical
Ca2+ transient, the on reactions are counteracted by the
off reactions, during which time various pumps and
exchangers remove Ca2+ from the cytoplasm (FIG. 1). The
pumping mechanisms also have important homeostatic
functions in that they maintain the resting level of Ca2+ at
approximately 100 nM and ensure that the internal stores
are kept loaded. Four different pumping mechanisms are
responsible for the off reaction — the PLASMA-MEMBRANE
Ca2+-ATPASE (PMCA), the Na+/Ca2+ EXCHANGER (NCX), SERCA
and the MITOCHONDRIAL UNIPORTER (FIG. 1).
These pumping mechanisms have different thresh-
olds for activity. PMCA and SERCA pumps have lower
transport rates but high affinities, which means that
they can respond to modest elevations in Ca2+ levels
and set basal Ca2+ levels. The NCX and mitochondrial
uniporter have much greater transport rates, and can
limit Ca2+ transients over a wider dynamic range. For
example, mitochondria accumulate Ca2+ even when
presented with modest nM global Ca2+ changes, but the
rate of mitochondrial Ca2+ uptake is optimal at µM Ca2+
concentrations57,58.
The diverse PMCA, SERCA and NCX molecular
toolkit (BOX 1) enables cells to select the combination of
off reactions that exactly meets their Ca2+-signalling
requirements. For example, cells, such as stereocilia,
skeletal and cardiac muscle, that generate rapid Ca2+
transients have PMCA isoforms (PMCA2a and
PMCA3f) that pump at fast rates, whereas cells that
produce slower Ca2+ transients to activate cell prolifera-
tion express PMCA4b that pumps much more slowly59.
scaffolding proteins spinophilin and PR130, respectively
(BOX 2, part a)44. The presence of these phosphatases in
the same protein complex as the kinase and substrate
ensure that there is a tight regulation of the phosphory-
lation status of the receptor and, therefore, its activity.
The membrane and luminal region of the RYR2 is pre-
sent in a complex with three other proteins: junctin, tri-
adin and calsequestrin (BOX 2, part a)47,48. Calsequestrin
is the principal Ca2+-binding protein of muscle cells and
is highly concentrated in the junctional region of the SR.
In the lumen of the SR, calsequestrin does not bind
directly to the RYR, but is anchored adjacent to the
Ca2+-release site through junctin and triadin, which are
both membrane-bound proteins (BOX 2, part a)48. Triadin
and junctin interact with calsequestrin in a Ca2+-depen-
dent manner48, and this interaction might account for
the sensitivity of RYR2s to Ca2+ in the lumen23,26. Indeed,
transgenic studies have shown that there is a significant
role for calsequestrin, junctin and triadin in cardiac Ca2+
signalling and hypertrophy (see below).
Emerging Ca2+ channels. AUTOSOMAL-DOMINANT POLYCYSTIC
KIDNEY DISEASE (ADPKD) has been linked to mutations in
two membrane-spanning proteins, which are known as
polycystin-1 (PC-1) and polycystin-2 (PC-2)49. PC-1
has a large extracellular domain and might function in
transducing sensory information, such as shear stress
during fluid flow49. PC-2 has been shown to function as
an intracellular Ca2+-release channel50 and to form a
non-selective cation channel when it is inserted into the
plasma membrane51. PC-2 has homology with VOCs
and TRP channels, and when expressed by itself it shows
spontaneous channel activity. Mutations in either pro-
tein somehow corrupts the PC-1–PC-2 complex, which
leads to abnormal Ca2+ signalling and, consequently,
altered rates of cell proliferation and function. These
proteins seem to have a widespread expression,
although their role outside the kidney is not well under-
stood. Interestingly, PC-2 is localized to the ER in some
cell types52, which indicates that it might be a ubiquitous
CICR channel.
Ca2+-binding proteins. During the on reaction (FIG. 1),
Ca2+ flows into the cell and interacts with different Ca2+-
binding proteins, of which there are ~200 encoded by
the human genome that function either as Ca2+ effectors
or buffers2.
The buffers, which become loaded with Ca2+ during
the on reaction and unload during the off reaction, func-
tion to fine-tune the spatial and temporal properties of
Ca2+ signals. They can alter both the amplitude and the
recovery time of individual Ca2+ transients. These buffers
have different properties and expression patterns. For
example, calbindin D-28 (CB) and calretinin (CR) are
fast buffers, whereas parvalbumin (PV) has much slower
binding kinetics and a high affinity for Ca2+. These are
mobile buffers that increase the diffusional range of Ca2+
(REF. 53). Of the Ca2+ that enters the cytosol, only a very
small proportion ends up being free, because most of it is
rapidly bound to the buffers and, to a lesser extent, the
effectors (FIG. 1). The Ca2+-BINDING RATIO (K
S
) is used to
AUTOSOMAL-DOMINANT
POLYCYSTIC KIDNEY DISEASE
(ADPKD). A fatal disease that is
characterized by the progressive
development of fluid-filled cysts
in the kidney, liver and pancreas.
Ca2+-BINDING RATIO
(K
S
). The ratio between the
amount of Ca2+ that is bound
compared to the Ca2+ that is free
in the cytosol.
PLASMA-MEMBRANE 
Ca2+-ATPASE
(PMCA). A pump on the plasma
membrane that couples ATP
hydrolysis to the transport of
Ca2+ from cytosolic to
extracellular spaces.
Na+/Ca2+ EXCHANGER
(NCX). A plasma-membrane
enzyme that exchanges three
moles of Na+ for one mole of
Ca2+, either inward or outward,
depending on the ionic
gradients across the membrane.
MITOCHONDRIAL UNIPORTER
A ‘channel’ that is located in the
inner mitochondrial membrane
that transports Ca2+ from the
cytosol into the mitochondrial
matrix.
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Cells respond to such oscillations using highly
sophisticated mechanisms, including an ability to inter-
pret changes in frequency. Such frequency-modulated
Ca2+ signalling occurs in many cells (for example, hepa-
tocytes, salivary glands, endothelial cells and smooth
muscle cells), in which it can regulate specific responses
such as exocytosis72, mitochondrial redox state73 and
differential gene transcription74–78. The molecular
machines that are responsible for decoding frequency-
modulated Ca2+ signals include CaMKII79 and PKC80.
The function of repetitive Ca2+ spiking in differential
gene transcription is explored more fully in the section
on cardiac hypertrophy.
Ca2+ waves. The Ca2+ signal that makes up Ca2+ oscilla-
tions often spreads through the cytoplasm as a regenera-
tive wave1, and depends on successive rounds of Ca2+
release and diffusion from clusters of Ins(1,4,5)P
3
Rs or
RYRs that are located on the ER/SR. In the case of
Ins(1,4,5)P
3
Rs, the channel clusters give rise to local signals
that are known as Ca2+ ‘puffs’,whereas RYRs generate Ca2+
‘sparks’. Typically, these elementary Ca2+ signals produce a
modest elevation of the cytosolic Ca2+ concentration
(~50–600 nM), with a limited spatial spread (~2–6 µm),
and reflect the transient opening of channels (duration
of <1 s)81,82. Ca2+ that is released by one channel cluster
can diffuse to a neighbouring site and activate it. This
SALTATORIC PROPAGATION mechanism allows the initial local
signal to trigger global Ca2+ waves and oscillations1.
In some cases, these waves are highly localized, for
example in starburst amacrine cells in the retina, in
which localized dendritic signals are used to compute
the direction of motion83. In addition to such intracellu-
lar waves, information can also spread from cell to cell
through intercellular waves as has been described in
endocrine cells84, the vertebrate gastrula85 and the intact
perfused liver86. In some cases, intercellular waves can
cross from one cell type to another as occurs between
endothelial and smooth muscle cells87.
On and off reactions in cardiac cells. The highly orga-
nized cardiac Ca2+-signalling module illustrates several
of the important dynamic aspects of Ca2+ signalling,
such as amplification, homeostasis, tunnelling and
modulation through crosstalk with other signalling
pathways (FIG. 3). Activation begins when the cardiac
action potential depolarizes the T-TUBULE to open the
L-type VOC to introduce a small pulse of trigger Ca2+ —
a ‘sparklet’88 — that diffuses across the JUNCTIONAL ZONE to
stimulate RYR2s (BOX 2, part a) to generate a spark. As
the sparklet activates a cluster of 4–6 RYR2s, the spark is
much larger and results in a considerable amplification
of the initial sparklet. The Ca2+ within the spark then
diffuses away from the junctional zone to induce con-
traction by activating sarcomeres that are situated in the
immediate vicinity. During the recovery phase, the off
reactions that were described earlier (FIG. 1) begin to
remove Ca2+ from the cytoplasm (FIG. 3).
An important feature of Ca2+ signalling is homeosta-
sis — cells avoid a net loss or gain of Ca2+ by ensuring
that the fluxes occurring during the on and off reactions
Recent studies have highlighted the contribution of a
hitherto unrecognized family of Ca2+ pumps in regulating
Ca2+ stores. These Ca2+ pumps, which are known as secre-
tory-pathway Ca2+-ATPases (SPCAs), are related to
SERCAs but have distinct functional properties and cellu-
lar roles60. It seems that SPCAs might be responsible for
Ca2+ sequestration into Golgi compartments. The expres-
sion of these pumps increases in lactotrophs before partu-
rition, and mutations can lead to HAILEY–HAILEY DISEASE,
which indicates that the maintenance of Golgi Ca2+ levels
by SPCAs is crucial in regulating secretion and cellular
contacts.
Spatial and temporal organization of Ca2+ signalling
In addition to the extensive Ca2+-signalling toolkit,
another factor that contributes to the versatility of Ca2+
signalling is its high degree of spatial and temporal
diversity1. Spatial properties are particularly relevant for
rapid responses when components of the on reactions
and their downstream effectors are closely associated.
This spatial contiguity is less apparent for slower
responses such as gene transcription and cell prolifera-
tion when Ca2+ signals are usually presented in the form
of repetitive Ca2+ transients and waves.
Spatial aspects of Ca2+ signalling. Many Ca2+-signalling
components are organized into macromolecular com-
plexes (BOX 2) in which Ca2+ signalling functions within
highly localized environments.These complexes can func-
tion as autonomous units, or modules, that can be multi-
plied,or mixed and matched, to create larger,more diverse
signalling systems. For example, the cardiac Ca2+-release
unit (FIG. 3) can be recruited independently of its neigh-
bours to produce graded contractions. Similarly, the indi-
vidual spines on neurons operate as autonomous Ca2+-
signalling units,which greatly increases the computational
capacity of neurons. For example, individual spines can
undergo input-specific, Ca2+-dependent synaptic modifi-
cations during the process of learning and memory.
Temporal aspects of Ca2+ signalling. Almost all Ca2+-sensi-
tive processes are tuned to respond to Ca2+ transients that
are generated by the on/off mechanisms that are summa-
rized in FIG. 1. At the fast end of the scale, for example,
synaptic transmission or cardiac contraction, the effector
systems respond to pulses within the microsecond to mil-
lisecond range. Moving up the timescale, the Ca2+ tran-
sients tend to last for longer (seconds to minutes) and the
resulting signal usually spreads out as a Ca2+ wave (see
below) to reach targets that are distributed throughout the
cell. During prolonged stimulation, these Ca2+ transients
are repeated to set up regular Ca2+ oscillations that have
been implicated in the control of many different processes,
such as oocyte activation at fertilization61, growth-cone
migration62, growth-cone turning63, axonal growth of cor-
tical neurons64,neuronal-cell migration65,development of
neurotransmitter phenotypes66, formation of nodules in
plant root hairs67, contributing to astrogliosis and epilepsy
in neocortical slices68, development of muscle69, release of
cytokines from renal epithelial cells70 and the disassembly
of adhesive structures during cell migration71.
HAILEY–HAILEY DISEASE
A rare autosomal-dominant skin
disease that is characterized by
disturbed keratinocyte adhesion.
SALTATORIC PROPAGATION
A mechanism by which Ca2+
signals leap from one group of
Ca2+ channels to the next.
T-TUBULE
(transverse tubule). A tubular
invagination of the plasma
membrane in a muscle fibre, the
function of which is to pass the
excitation signal from the
muscle-cell surface to the
sarcomeres, to ensure rapid and
synchronous activation.
JUNCTIONAL ZONE
The narrow space that is located
between the T-tubule and
sarcoplasmic reticulum in
cardiac cells in which the process
of excitation–contraction
coupling occurs.
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SERCA pump is also enhanced by cADPR23. Third,
cAMP/PKA phosphorylates the RYRs, thereby enhanc-
ing their ability to release Ca2+ to form sparks45.
The expression of the individual components of this
cardiac Ca2+-signalling module, as for Ca2+-signalling sys-
tems in other cells, is constantly under review. The next
section describes how Ca2+ has a direct role in remodel-
ling its signalling pathways in both health and disease.
Remodelling Ca2+-signalling systems
The full exploitation of the Ca2+-signalling toolkit
depends on differential gene transcription to assem-
ble diverse Ca2+-signalling systems. However, such
cell-specific Ca2+ SIGNALSOMES are not fixed in stone, in
that they are constantly being remodelled to ensure
that each cell type continues to deliver the Ca2+ sig-
nals that characterize its unique function. It seems
that each cell has a signalling blueprint and ‘knows’
exactly what kind of signal it is expected to deliver. If
the spatio-temporal properties of this output signal
change because of a loss or defect of a key compo-
nent, compensatory mechanisms come into play to
restore the normal output signal. This remodelling
process indicates that there is an element of quality
assessment, in that the output of the signalling sys-
tem is constantly monitored. We propose the hypoth-
esis that Ca2+ itself has an important function in this
internal assessment mechanism by remodelling its
own signalling pathway (FIG. 4).
Ca2+-induced Ca2+-signalling remodelling. The central
pillars of this Ca2+-induced Ca2+-signalling remodelling
hypothesis are that Ca2+ is a potent activator of gene
transcription2,90–93, and that some of the genes that are
activated code for components of the Ca2+-signalling
toolkit. The various Ca2+-dependent transcription fac-
tors (BOX 1) are activated by different mechanisms. In the
case of downstream regulatory element modulator
(DREAM), which functions as a repressor, Ca2+ that
enters the nucleus functions by removing DREAM from
its DNA-binding site91. Ca2+ can also function indirectly
through protein kinases (CaMKII and CaMKIV) or pro-
tein phosphatases (for example, calcineurin) to alter the
phosphorylation state of various transcription factors
(FIG. 5). Alternatively, Ca2+ can promote gene transcrip-
tion by recruiting either the Ras/mitogen-activated pro-
tein kinase (MAPK)- or cAMP-signalling pathways.
There is increasing evidence that Ca2+ can alter the
expression level of Ca2+-signalling components such as
pumps and channels94–98 (FIG. 4). The Ca2+-dependent
development of cerebellar granular neurons was marked
by an upregulation of Ins(1,4,5)P
3
R and two PMCA iso-
forms, PMCA2 and PMCA3. On the other hand,
PMCA4 and the type 2 NCX (NCX2) were rapidly
downregulated94,96. Some of these changes, such as
the expression of Ins(1,4,5)P
3
R, are mediated through
the calcineurin/nuclear factor of activated T cells
(NFAT) transcriptional cascade97,98.
This ability of Ca2+ to regulate its signalling path-
ways might help to explain the ability of the system to
compensate for changes in the activity of individual
are always balanced. Homeostasis is particularly impor-
tant in cardiac cells, in which there is a large circulation
of Ca2+ with every heart beat (FIG. 3). For homeostasis to
occur, the same amount of Ca2+ that enters through the
L-type channel during the on reaction must be removed
by the NCX during the off reaction. Likewise, the same
amount of Ca2+ that is released by the RYR2s is returned
to the SR by the SERCA pump. As the SERCA pumps
are distributed over the non-junctional regions of the
SR, the newly pumped Ca2+ has to ‘tunnel’ its way
through the SR lumen to reach the junctional region to
become available for subsequent release cycles. This part
of the recovery process is complicated by the fact that a
proportion of the released Ca2+ travels through the
mitochondria while en route to the SERCA pump, and
this is particularly evident in neonatal cells89. While in
transit, Ca2+ within the mitochondrial matrix activates
the metabolism that ensures that the formation of ATP
is maintained at the required rate to sustain contraction.
The force of contraction can be adjusted by varying
the amount of Ca2+ that circulates during each on/off
cycle. The positive INOTROPIC response that is produced
by β-adrenergic stimulation is mediated by cyclic
AMP/PKA, which has three main actions on Ca2+ sig-
nalling. First, it stimulates the L-type VOCs to increase
the amount of Ca2+ that enters during each action
potential. Second, it phosphorylates phospholamban to
reduce its inhibitory effect on the SERCA pump, which
is then able to increase the luminal Ca2+ concentration
so that more Ca2+ is released from the SR — as
described earlier, an increase in the activity of the
Figure 4 | A calcium-induced calcium-signalling remodelling hypothesis. Cell-specific Ca2+
signalsomes that are created by selecting components from the Ca2+-signalling toolkit (BOX 1)
generate Ca2+ transients that are characteristic for each cell type. It is proposed that the Ca2+
transient has two functions. In addition to activating cellular responses, it also functions as part of
a feedback mechanism to regulate the transcriptional events that are responsible for maintaining
the signalsome. This Ca2+-dependent transcriptional regulation might have a central role in the
compensatory mechanisms that enable cells to adapt to any modifications of their Ca2+-signalling
systems. It seems that Ca2+ can adjust transcriptional activity both positively and negatively.
Diseases such as manic depression, hypertension, diabetes and congestive heart failure might
develop from a failure of this proposed phenotypic remodelling system.
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altered phenotype owing to the expression of neonatal
genes. This initial hypertrophy is a compensatory
change, because the heart returns to its original pheno-
type and size if the abnormal inputs are reduced.
However, if the stresses persist, this compensated hyper-
trophy shifts to a state of congestive heart failure, which
is more difficult to reverse than compensatory hypertro-
phy. The phenotypic remodelling that occurs during
cardiac hypertrophy and congestive heart failure is con-
trolled by several signalling pathways in which Ca2+ has
a prominent role (FIG. 5).
This central role of Ca2+ signalling in cardiac hyper-
trophy is apparent from studies on transgenic mice in
which the overexpression of genes encoding components
of this pathway (FIG. 5), such as the L-type Ca2+ channel102,
calcineurin and NFAT103, triadin 1 (REF 104), junctin105,
calsequestrin106 and G
qα
(REF. 107), all result in hypertro-
phy. Transgenic mice that overexpress calsequestrin have
a particularly marked phenotype that is characterized by
severe cardiac hypertrophy and decreased depolarization-
induced Ca2+ release from the SR. The overexpression of
calsequestrin resulted in a compensatory decrease in the
components99. Compensatory changes in Ca2+ sig-
nalling have also been recorded in cells from mice that
carry a null mutation in one copy of the SERCA2 gene,
which resembles the mutation that is found in DARIER’S
DISEASE. Despite a 40–60% decline in the Ca2+ content of
the intracellular store, the mouse cardiac cells were still
able to generate moderate Ca2+ spikes through com-
pensatory changes in the expression levels of phospho-
lamban and NCX100. Exocrine glands adjusted to the
same mutation by upregulating specific PMCA iso-
forms (PMCA3 and PMCA4) and by adjusting the levels
of its Ca2+ sensors to increase the sensitivity of exocyto-
sis101. Each cell type adopted a different strategy to over-
come the same mutation, thereby emphasizing the
flexibility of Ca2+-signalling remodelling systems.
Cardiac hypertrophy. Several important disease states
(hypertension, heart disease, diabetes, manic depression
and Alzheimer’s disease) might result from abnormal
remodelling of the Ca2+ signalsome. A good example is
CONGESTIVE HEART FAILURE, which begins when the heart
adapts to stress by increasing in size and by showing an
DARIER’S DISEASE
An autosomal-dominant skin
disorder.
CONGESTIVE HEART FAILURE
A syndrome that is characterized
by the failure of the heart to
maintain the circulation of the
blood adequately.
Figure 5 | Signalling pathways that participate in the control of compensatory hypertrophy. A key element of this remodelling
process is the Ca2+ that is released by the cardiac signalling module (FIG. 3). This Ca2+ signal is enhanced during hypertrophy by the
adrenergic pathway that functions through adenylyl cyclase (AC) to increase cyclic AMP (cAMP), which enhances signalling by
phosphorylating the entry channel (CaV1.2), ryanodine receptor 2 (RYR2) and phospholamban (PLN). Ca
2+ functions through calcineurin
(CN) to dephosphorylate the transcription factor NFAT3, thereby enabling it to enter the nucleus to induce the transcription of genes,
some of which are fetal genes. Hypertrophy can also be enhanced by angiotensin II and endothelin that function through Gq and
phospholipase C-β (PLCβ) to generate inositol-1,4,5-trisphosphate (Ins(1,4,5)P3), which could enhance Ca2+, and diacylglycerol (DAG),
which seems to function by recruiting the mitogen-activated protein kinase (MAPK)-signalling pathway to stimulate cAMP response
element-binding protein (CREB). The phosphatidylinositol 3-kinase (PI3K)-signalling pathway, which is activated by insulin-like growth
factor (IGF-1), contributes to hypertrophy by inhibiting the glycogen synthase kinase 3 (GSK-3) that inactivates NFAT3, by stimulating
Bcl-associated death promoter (BAD) to inhibit apoptosis and by stimulating p70S6k (70-kD ribosomal S6 kinase) to stimulate the
expression of the newly transcribed genes. Cav-3, caveolin-3; GATA4, zinc-finger transcription factor; HDAC, histone deacetylase;
MEF2, myocyte enhancer factor 2; MEK, MAPK kinase; NFAT, nuclear factor of activated T cells; PDK, phosphoinositide-dependent
protein kinase; PKB, protein kinase B; PKC, protein kinase C; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PtdIns(3,4,5)P3,
phosphatidylinositol-3,4,5-trisphosphate; SOS, Son of sevenless; TnC, troponin C.
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transcription, and some of the genes transcribed will be
fetal genes. It is this change in the dynamics of the Ca2+
transient that seems to carry the information that is
responsible for inducing hypertrophy.
A different phenotypic remodelling process occurs
during the onset of congestive heart failure when the
amplitudes of the Ca2+ transients are much reduced
owing to a severe downregulation of the Ca2+-signalling
system. One of the most noticeable changes is a decline in
the activity of the SERCA pump that is due, in part, to the
enhanced inhibition through phospholamban116, which
results in the severe depletion of the SR store that charac-
terizes congestive heart disease117. One reason for this
decline in Ca2+ signalling is a marked downregulation of
β-adrenergic-receptor signalling118. During compen-
satory hypertrophy, an increased release of cate-
cholamines contributes to the hypertrophic response by
activating the cAMP pathway that enhances Ca2+ sig-
nalling (FIG. 5). This enhancement of Ca2+ signalling is
seriously compromised when the β-adrenergic-signalling
system is downregulated during congestive heart failure.
The severity of congestive heart failure might arise
when this downregulation of the β-adrenergic-signalling
system coincides with a Ca2+-induced Ca2+-signalling
remodelling process to switch off the expression of key
components such as the SERCA pumps. It is the coinci-
dence of these two regulatory events that might explain
the severe disfunction of the Ca2+ uptake and storage
capacity, which results in the weak transients that charac-
terize the failing human heart117.
Conclusion
There are numerous Ca2+-signalling systems that are
designed to regulate many different cellular processes.
This versatility is achieved by the existence of an exten-
sive Ca2+-signalling toolkit that is used to assemble these
cell-specific signalsomes that can deliver Ca2+ signals
with the spatial and temporal characteristics that are
necessary for its many control functions. A major chal-
lenge for the future is to determine the differential
transcription and expression mechanisms that are
responsible for putting together these different sig-
nalling pathways. In addition, it will be important to
establish the quality-assessment mechanisms that are
responsible for maintaining the integrity of these sig-
nalling pathways. There is already some indication that
Ca2+ itself might function in regulating the stability of
its signalling pathways. This Ca2+-dependent quality-
assessment mechanism warrants further attention,
because there are indications that several pathologies,
such as cardiac disease, might develop after the abnor-
mal remodelling of Ca2+ signalling.
expression of its binding partners (junctin, triadin and
RYR2) within the RYR2 complex (BOX 2, part a)106,108.
Conversely, hypertrophy can be prevented by either inac-
tivating components such as G
qα
(REF. 109) or by promot-
ing the activity of glycogen synthase-3 (GSK-3), which
inactivates the Ca2+-sensitive transcription factor
NFAT110 (FIG. 5). Ablating phospholamban was able to
rescue the hypertrophy that resulted from  the overex-
pression of calsequestrin111, but not hypertrophy caused
by overexpressing G
qα
(REF. 112). The effect of manipulat-
ing phospholamban seems to depend on the initial cause
of hypertrophy, and this might explain why the effects of
ablating this regulator in mice are very different to those
seen in humans113. In humans, hypertrophy and heart
disease developed in individuals carrying a mutation
that results in the deletion of phospholamban, thereby
emphasizing the significance of alterations in Ca2+ sig-
nalling as a cause of heart failure in humans113.
A major problem in trying to understand how Ca2+
controls cardiac hypertrophy is the fact that the heart is
continuously subjected to large periodic Ca2+ signals
(FIG. 3) that flood through the cytoplasm and nucleus
every time the heart contracts.Why is it then that cardiac
cells subjected to this constant barrage of Ca2+ avoid trig-
gering a hypertrophic response? It has been suggested
that the normal functioning heart might not be tran-
scriptionally silent, but might be under constant Ca2+-
dependent control114. In other words, the transcriptional
events that are responsible for regulating the expression
of the cardiac signalsome are continuously assessed as
proposed earlier for the Ca2+-induced Ca2+-signalling
remodelling hypothesis (FIG. 4). If this is the case, then the
increase in transcription during hypertrophy might
result from subtle alterations in the spatio-temporal
properties of the individual Ca2+ spikes. Indeed, a broad-
ening of the Ca2+ transient or an increase in its amplitude
has been recorded in cases in which hypertrophy is
induced by modifying the levels of proteins that associate
with RYR2 (BOX 2, part a), such as triadin104 or FKBP12.6
(REF. 115), respectively. The hypertrophy that occurred in
the FKBP12.6 –/– mice failed to develop in the females,
who might be protected against the hypertrophic effect
of Ca2+ by female sex hormones such as oestrogen. The
failure of phospholamban ablation to prevent hypertro-
phy112 might be explained by the fact that these trans-
genic animals had a large increase in the amplitude of the
Ca2+ transients. In all of these cases, the rising phase that
is responsible for triggering contraction remains the
same, but the increase in amplitude or spike broadening
enhances the extent of the Ca2+ pulse. These subtle
changes in the individual spikes might be integrated
over time to stimulate a distinct programme of gene
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